http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113684274-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2020-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113684274-B |
| titleOfInvention | Kit for diagnosing and treating malignant female germ cell tumor |
| abstract | The invention relates to a kit for diagnosing and treating female malignant germ cell tumor, which comprises a detection reagent for OVOL2 expression level and a cisplatin drug for chemotherapy. By adopting the kit for diagnosing and treating the female malignant germ cell tumor, the sensitivity of the female malignant germ cell tumor to cisplatin chemotherapy can be predicted in advance, so that a treatment scheme is optimized, unnecessary chemotherapy is reduced, the life quality of a patient is improved, and the prognosis of the patient is improved. |
| priorityDate | 2020-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 167.